QSS
Quantitative Systematic Strategies Portfolio holdings
AUM
$11.5M
1-Year Return
21.99%
This Quarter Return
-15.25%
1 Year Return
+21.99%
3 Year Return
+132.84%
5 Year Return
+157.46%
10 Year Return
–
AUM
$446M
AUM Growth
-$80.4M
(-15%)
Cap. Flow
-$25.8M
Cap. Flow
% of AUM
-5.8%
Top 10 Holdings %
Top 10 Hldgs %
8.38%
Holding
953
New
347
Increased
168
Reduced
160
Closed
277
Top Buys
| 1 |
Colgate-Palmolive
CL
|
+$3.01M |
| 2 |
HDS
HD Supply Holdings, Inc.
HDS
|
+$2.82M |
| 3 |
T-Mobile US
TMUS
|
+$2.57M |
| 4 |
Intuit
INTU
|
+$2.45M |
| 5 |
Masco
MAS
|
+$2.42M |
Top Sells
| 1 |
TSS
Total System Services, Inc.
TSS
|
+$4.53M |
| 2 |
Philip Morris
PM
|
+$3.66M |
| 3 |
Waste Connections
WCN
|
+$3.36M |
| 4 |
Prologis
PLD
|
+$3.26M |
| 5 |
Equity Lifestyle Properties
ELS
|
+$3.05M |
Sector Composition
| 1 | Financials | 22.35% |
| 2 | Real Estate | 13.44% |
| 3 | Industrials | 10.7% |
| 4 | Healthcare | 8.92% |
| 5 | Technology | 8.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
451
Option Care Health
OPCH
$4.66B
| $265K | 0.06% |
+18,533
| New | +$265K |
|
452
Varonis Systems
VRNS
$6.41B
| $263K | 0.06% |
14,937
-14,055
| -48% | -$247K |
|
453
Vertex Pharmaceuticals
VRTX
$99.6B
| $263K | 0.06% |
+1,587
| New | +$263K |
|
454
WEX
WEX
$5.81B
| $262K | 0.06% |
1,874
-8,562
| -82% | -$1.2M |
|
455
Goodyear
GT
$2.45B
| $261K | 0.06% |
12,766
-1,698
| -12% | -$34.7K |
|
|
LJPC
456
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $261K | 0.06% |
+27,725
| New | +$261K |
|
|
FOCS
457
DELISTED
Focus Financial Partners Inc. Class A
FOCS
| $256K | 0.06% |
9,737
-5,129
| -35% | -$135K |
|
458
Equitable Holdings
EQH
$15.8B
| $254K | 0.06% |
+15,272
| New | +$254K |
|
459
Trinity Industries
TRN
$2.28B
| $250K | 0.06% |
12,139
-4,418
| -27% | -$91K |
|
460
eBay
EBAY
$41.7B
| $248K | 0.06% |
8,825
-32,014
| -78% | -$900K |
|
461
Pembina Pipeline
PBA
$22.5B
| $247K | 0.06% |
+8,321
| New | +$247K |
|
462
Turkcell
TKC
$4.79B
| $247K | 0.06% |
+43,982
| New | +$247K |
|
463
Akebia Therapeutics
AKBA
$777M
| $246K | 0.06% |
44,507
+21,582
| +94% | +$119K |
|
464
Assertio
ASRT
$77.5M
| $246K | 0.06% |
+17,064
| New | +$246K |
|
465
Coca-Cola Consolidated
COKE
$10.5B
| $246K | 0.06% |
+13,870
| New | +$246K |
|
466
Amicus Therapeutics
FOLD
$2.45B
| $246K | 0.06% |
+25,641
| New | +$246K |
|
467
Steris
STE
$24B
| $246K | 0.06% |
+2,306
| New | +$246K |
|
468
Tandem Diabetes Care
TNDM
$836M
| $246K | 0.06% |
+6,470
| New | +$246K |
|
|
SYKE
469
DELISTED
SYKES Enterprises Inc
SYKE
| $246K | 0.06% |
+9,963
| New | +$246K |
|
470
Crown Holdings
CCK
$11B
| $245K | 0.05% |
5,888
-2,823
| -32% | -$117K |
|
471
Jefferies Financial Group
JEF
$13.5B
| $245K | 0.05% |
+15,769
| New | +$245K |
|
472
Sherwin-Williams
SHW
$89.1B
| $242K | 0.05% |
1,842
-4,215
| -70% | -$554K |
|
|
ARCH
473
DELISTED
Arch Resources, Inc.
ARCH
| $242K | 0.05% |
+2,914
| New | +$242K |
|
474
Surmodics
SRDX
$459M
| $240K | 0.05% |
+5,069
| New | +$240K |
|
475
United Airlines
UAL
$34.8B
| $239K | 0.05% |
2,849
-23,662
| -89% | -$1.98M |
|